Viewing Study NCT07085104


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-03-27 @ 8:28 AM
Study NCT ID: NCT07085104
Status: RECRUITING
Last Update Posted: 2025-07-25
First Post: 2025-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Sponsor: Allogene Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ALLO-329-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators